The third dose of a COVID-19 vaccine boosts antibody levels
the verdict
SUPPORTED
the evidence backs this
confidence 84/100
Clinical studies consistently show that administering a third dose of a COVID-19 vaccine substantially increases antibody levels and enhances immune protection.
Evidence for · 4
Significant Increase in Antibody Titers after the 3rd Booster Dose of the Pfizer–BioNTech mRNA COVID-19 Vaccine in Healthcare Workers in Greece
2022 · cited by 23
Paper 0 found that the third booster dose of the Pfizer-BioNTech vaccine significantly increased anti-S1 RBD IgG antibody titers in healthcare workers.
See more details
More for · 3
Third BNT162b2 Vaccine Booster Dose against SARS-CoV-2-Induced Antibody Response among Healthcare Workers
2022 · cited by 8
Paper 1 reported that the third BNT162b2 booster dose improved immunogenicity by yielding higher antibody concentrations among tested healthcare workers.
Antibody Response after 3-Dose Booster against SARS-CoV-2 mRNA Vaccine in Kidney Transplant Recipients
2024 · cited by 3
Paper 2 observed a significant increase in antibody response post-booster among kidney transplant recipients.
Immunogenicity and Safety of the Third Booster Dose with Homologous or Heterologous COVID-19 Vaccine After Completing Primary Series of Inactivated Vaccine (CoronaVac) or Adenovirus Vector Vaccine (AZD1222) in Thai Adults
cited by 0
Paper 4 demonstrated that heterologous booster vaccines significantly enhance binding and neutralizing antibody levels following primary vaccination series.